COMMUNIQUÉS West-GlobeNewswire

ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma

25/04/2025 - 19:10

- Data to be presented at AACR 2025 Annual Meeting suggest the combination of ALX Oncology’s investigational CD47-blocker, evorpacept, plus rituximab and lenalidomide (R 2 ) was well-tolerated and demonstrated promising [...]

Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC

25/04/2025 - 19:17

Gene signatures associated with increased efficacy of micvotabart pelidotin (MICVO) due to greater linker cleavage were identified based on differential gene expression analysis of PDX responders/non-responders Mouse [...]

Tevogen Bio Announces 2025 Annual Meeting

25/04/2025 - 20:33

WARREN, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen Bio” or “Company”) (Nasdaq: TVGN ) today announced that the Company will hold its 2025 annual meeting of stockholders (the “Annual [...]

Clenbuterol Bodybuilding (Clen) Pills, Clenbuterol Dosage, Clenbuterol, Benefits, Clenbuterol Side Effects, Clenbuterol Cycles, Where to buy Clenbuterol tablet buy, ambroxol, lavizoo (CrazyBulk)

25/04/2025 - 21:18

New York City, April 25, 2025 (GLOBE NEWSWIRE) -- Why Do People Look for Weight Loss Pills? Many people want a leaner body and look for pills to help them achieve this. One such pill is Clenbuterol , which is often used [...]

Spanios and White Lion Capital LLC Announce Strategic Partnership to Accelerate Drug Development

25/04/2025 - 21:26

HOUSTON, April 25, 2025 (GLOBE NEWSWIRE) -- Spanios, a leader in human-derived organoid model systems, is pleased to announce a strategic partnership with White Lion Capital LLC. This collaboration empowers biotech and [...]

Oculis Updates Share Capital

25/04/2025 - 22:00

ZUG, Switzerland, April 25, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company, has issued registered ordinary shares of the Company, each [...]

CHMP recommends EU approval for Duvyzat to treat Duchenne muscular dystrophy

25/04/2025 - 16:17

Recommendation is based on Phase 3 EPIDYS trial data that demonstrated Duvyzat (givinostat) provides statistically and clinically meaningful treatment benefits in individuals with Duchenne muscular dystrophy (DMD) If [...]

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

25/04/2025 - 16:20

ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 25 April 2025 at 17.20 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]

2024 Annual Report Vistin Pharma ASA

25/04/2025 - 16:40

Oslo, Norway, 25 April 2025 Please find attached the Annual Report for 2024 for Vistin Pharma ASA (VISTN). There are no material changes in the financial statements compared to the preliminary full year results [...]

Mental Health Nonprofit Queer LifeSpace to Host Annual Fundraising Gala "Pride Renaissance: Celebrating Community Resilience"

25/04/2025 - 17:19

Biggest fundraising gala in organization’s history aims to raise $75,000 for accessible, queer-affirming mental health care SAN FRANCISCO, April 25, 2025 (GLOBE NEWSWIRE) -- In the midst of a worsening mental health [...]

My Grief Angels Inc Launches Mother's Day "Bouquet of Support" for Grieving Moms

25/04/2025 - 17:25

A Compassionate Mother's Day Initiative for Mothers Grieving THE WOODLANDS, Texas, April 25, 2025 (GLOBE NEWSWIRE) -- As Mother's Day approaches, My Grief Angels Inc, a renowned 501(c)(3) public charity, is extending a [...]

Press release: Transparency Notification from Shareholders

25/04/2025 - 18:00

Transparency Notification from Shareholders Ghent, Belgium – 25 April 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the treatment of drug-resistant fluid [...]

Le Parlement est en pleine campagne « poil » itique : Le vote est ouvert pour le concours photo « Les animaux de compagnie les plus mignons sur la Colline du Parlement »

25/04/2025 - 18:00

OTTAWA, 25 avr. 2025 (GLOBE NEWSWIRE) -- L’Institut canadien de la santé animale (ICSA) est ravi d’annoncer que le vote du public est maintenant ouvert pour le 3e concours annuel de photos « Les animaux les plus mignons [...]

Parliament Gets Paw-litical: Voting Open for Cutest Pets on Parliament Hill Photo Contest

25/04/2025 - 18:00

OTTAWA, April 25, 2025 (GLOBE NEWSWIRE) -- The Canadian Animal Health Institute (CAHI) is thrilled to announce that public voting is now open for the 3rd Annual Cutest Pets on Parliament Hill photo contest! Canadians [...]

Juvent Launches Next Generation Bone Health Supplement HydroxyBMD3 at the National Bone Health & Osteoporosis Foundation (BHOF) Symposium in Washington, DC

25/04/2025 - 18:04

OOLTEWAH, Tenn., April 25, 2025 (GLOBE NEWSWIRE) -- Juvent, an innovator in clinically validated bone and musculoskeletal health solutions, debuted its revolutionary new supplement system HydroxyBMD 3 at the National [...]

Best SARMs for Bulking, Cutting, Fat Loss & Muscle Growth: Top Selective Androgen Receptor Modulators Reviewed for Lean Gains & Shredded Physique From CrazyBulk

25/04/2025 - 18:36

Discover the best SARMs for bulking, cutting, fat loss, and muscle growth in 2025. Boost strength, shred fat, and enhance performance naturally with powerful, legal SARMs alternatives. New York City, April 25, 2025 ( [...]

Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025

25/04/2025 - 19:00

CINCINNATI, April 25, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® wearable drug delivery platform, announced today the [...]

Nurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology Targets

25/04/2025 - 19:00

Nurix's lead BTK degrader, bexobrutideg, demonstrates exceptional efficiency, with a single molecule degrading approximately 10,000 copies of BTK per hour BRAF degrader demonstrates broad activity across all three BRAF [...]

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

25/04/2025 - 19:00

BDC-3042 was well tolerated up to 10 mg/kg q2w with no dose-limiting toxicities and no drug-related serious adverse events BDC-3042 showed biological activity, with clear dose-dependent increases in proinflammatory [...]